Trial Profile
Effects of Plasma-Derived C1 Inhibitor Concentrate on Risk of Thromboembolism in Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Aug 2015
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Hereditary angioedema
- Focus Adverse reactions
- 07 Aug 2015 New trial record